Review



rat osteogenic sarcoma cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    ATCC rat osteogenic sarcoma cell line
    Rat Osteogenic Sarcoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 411 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat osteogenic sarcoma cell line/product/ATCC
    Average 95 stars, based on 411 article reviews
    rat osteogenic sarcoma cell line - by Bioz Stars, 2026-05
    95/100 stars

    Images



    Similar Products

    95
    ATCC rat osteogenic sarcoma cell line
    Rat Osteogenic Sarcoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat osteogenic sarcoma cell line/product/ATCC
    Average 95 stars, based on 1 article reviews
    rat osteogenic sarcoma cell line - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    90
    Dawley Inc umr-106 rat osteogenic sarcoma cell line
    Umr 106 Rat Osteogenic Sarcoma Cell Line, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/umr-106 rat osteogenic sarcoma cell line/product/Dawley Inc
    Average 90 stars, based on 1 article reviews
    umr-106 rat osteogenic sarcoma cell line - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    95
    ATCC rat osteogenic sarcoma line umr 106
    Rat Osteogenic Sarcoma Line Umr 106, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat osteogenic sarcoma line umr 106/product/ATCC
    Average 95 stars, based on 1 article reviews
    rat osteogenic sarcoma line umr 106 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    95
    ATCC rat osteogenic sarcoma line
    Electrophoretic mobility shift analysis of core binding factor activity in cell extracts. Nuclear extracts were derived from T47i lymphoma cells (lanes 2–5), UMR 106 rat <t>osteogenic</t> sarcoma cells (lanes 6–9), or E86 mouse fibroblasts (lanes 10–13). No extract was added to lane 1. All reactions included nonspecific competitor poly-dI-dC, whereas those in lanes 3, 7, and 11 included an excess (100×) of unlabeled target oligonucleotide. Antiserum to the C terminus of the G1 isoform (see Fig. ​Fig.2)2) was added in lanes 4, 8, and 12, along with an excess of the corresponding glutathione S-transferase fusion protein in lanes 5, 9, and 13. The letters a and b indicate the major bandshift and supershift complexes observed with the T47i and UMR106 extracts.
    Rat Osteogenic Sarcoma Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat osteogenic sarcoma line/product/ATCC
    Average 95 stars, based on 1 article reviews
    rat osteogenic sarcoma line - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    Image Search Results


    Electrophoretic mobility shift analysis of core binding factor activity in cell extracts. Nuclear extracts were derived from T47i lymphoma cells (lanes 2–5), UMR 106 rat osteogenic sarcoma cells (lanes 6–9), or E86 mouse fibroblasts (lanes 10–13). No extract was added to lane 1. All reactions included nonspecific competitor poly-dI-dC, whereas those in lanes 3, 7, and 11 included an excess (100×) of unlabeled target oligonucleotide. Antiserum to the C terminus of the G1 isoform (see Fig. ​Fig.2)2) was added in lanes 4, 8, and 12, along with an excess of the corresponding glutathione S-transferase fusion protein in lanes 5, 9, and 13. The letters a and b indicate the major bandshift and supershift complexes observed with the T47i and UMR106 extracts.

    Journal:

    Article Title: Proviral insertions induce the expression of bone-specific isoforms of PEBP2?A (CBFA1): Evidence for a new myc collaborating oncogene

    doi:

    Figure Lengend Snippet: Electrophoretic mobility shift analysis of core binding factor activity in cell extracts. Nuclear extracts were derived from T47i lymphoma cells (lanes 2–5), UMR 106 rat osteogenic sarcoma cells (lanes 6–9), or E86 mouse fibroblasts (lanes 10–13). No extract was added to lane 1. All reactions included nonspecific competitor poly-dI-dC, whereas those in lanes 3, 7, and 11 included an excess (100×) of unlabeled target oligonucleotide. Antiserum to the C terminus of the G1 isoform (see Fig. ​Fig.2)2) was added in lanes 4, 8, and 12, along with an excess of the corresponding glutathione S-transferase fusion protein in lanes 5, 9, and 13. The letters a and b indicate the major bandshift and supershift complexes observed with the T47i and UMR106 extracts.

    Article Snippet: Northern blot analysis with the til -1E probe revealed faint signals at 5.5 kb from UMR106, a rat osteogenic sarcoma line (ATCC CRL-1661) (not shown).

    Techniques: Electrophoretic Mobility Shift Assay, Binding Assay, Activity Assay, Derivative Assay